PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$8.84
-0.15 (-1.67%)
Open$8.89
Previous Close$8.99
Day High$8.98
Day Low$8.81
52W High$11.80
52W Low$7.73
Volume—
Avg Volume345.0K
Market Cap432.51M
P/E Ratio—
EPS$-0.83
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+52.9% upside
Current
$8.84
$8.84
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.32M | 16.51M | 162.70M |
| Net Income | -234,883,580 | -374,614,960 | -26,550,677 |
| Profit Margin | -2,520.6% | -2,394.5% | -16.3% |
| EBITDA | -205,679,821 | -346,262,324 | -39,466,979 |
| Free Cash Flow | — | — | -19,760,246 |
| Rev Growth | -43.6% | -43.6% | +13.5% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |